Administration of Influenza Vaccine Procedure

Moderna Says FDA Will Consider Its New Flu Shot

FDA won’t consider a new mRNA vaccine for flu despite the technology’s life-saving promise

The U.S. Food and Drug Administration is refusing to consider a new mRNA flu vaccine made by Moderna, the company revealed in a statement on Tuesday.

· 1d

Moderna Says the FDA Will Consider Its New Flu Shot After Resolving a Public Dispute

· 17h

FDA reverses course on Moderna flu shot

· 1d

FDA reverses course and will review Moderna’s mRNA flu shot, company says

The US Food and Drug Administration has reversed course and will review a new mRNA flu vaccine from Moderna, the pharmaceutical company said Wednesday.

· 1d

FDA reverses course, will review Moderna's mRNA flu vaccine

· 1d

FDA Reverses Course and Will Now Review Moderna’s Flu Shot

Opinion

Public Broadcasting Service (PBS)Opinion

U.S. rejection of new mRNA flu vaccine 'sends chills,' epidemiologist says

The U.S. Food and Drug Administration announced recently that it will not review Moderna’s mRNA flu vaccine, despite late-stage trials showing it was safe and effective. The rejection has many in and outside the industry concerned about the Trump administration’s approach to vaccine development and recommendations.

Healio

Administration of some influenza vaccines linked to low risk for nodules, benign tumors

Please provide your email address to receive an email when new articles are posted on . Incorrect injection of an influenza vaccine can cause nodule formation or lipomas. Risk was lower when clinicians used trivalent vaccine formulations. Nodule and lipoma ...